What is it about?

This open-access review paper describes various types of liposome nanoparticles that have been used to encapsulate chemotherapy drugs, enabling them to target cancer cells.

Featured Image

Why is it important?

Cancer is a life-threatening disease contributing to ~3.4 million deaths annually worldwide. The main clinical failure of chemotherapy drugs is that they are administered systemically (all around the body) and a low concentration is delivered to the target cancer site. Increasing the dose only exposes normal cells to the cytotoxic drug causing harmful side effects. Encapsulation of anti-cancer drugs within nanoparticles is a powerful method of making targeted delivery of the therapeutic agent to the cancer cells. Liposomes are a type of nanoparticle that are particularly easy to produce, to functionalise and can be made small enough to take drugs across the blood-brain-barrier, which prevents many potential drugs from reaching the brain to treat brain tumours.


This paper is open access from the Journal webpage.

Dr James R Smith
University of Portsmouth

Read the Original

This page is a summary of: Liposomal Drug Delivery Systems and Anticancer Drugs, Molecules, April 2018, MDPI AG,
DOI: 10.3390/molecules23040907.
You can read the full text:



The following have contributed to this page